| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Cell Biology and Physiology [C. J. R-O., C. E. R., H. P-W.], Department of Internal Medicine [H. P-W.], Howard Hughes Medical Institute [C. E. R., H. P-W.], Washington University School of Medicine, St. Louis, Missouri 63110
The mitotic inducer Cdc2 is negatively regulated, in part, by phosphorylation on tyrosine 15. Human Wee1 is a tyrosine-specific protein kinase that phosphorylates Cdc2 on tyrosine 15. Human Wee1 is subject to multiple levels of regulation including reversible phosphorylation, proteolysis, and protein-protein interactions. Here we have investigated the contributions made by 14-3-3 binding to human Wee1 regulation and function. We report that the interactions of 14-3-3 proteins with human Wee1 are reduced during mitosis and are stable in the presence of the protein kinase inhibitor UCN-01. A mutant of Wee1 that is incapable of binding to 14-3-3 proteins has lower enzymatic activity, and this likely accounts for its reduced potency relative to wild-type Wee1 in inducing a G2 cell cycle delay when overproduced in vivo. These findings indicate that 14-3-3 proteins function as positive regulators of the human Wee1 protein kinase.
This article has been cited by other articles:
![]() |
A. N. Tse, T. N. Sheikh, H. Alan, T.-C. Chou, and G. K. Schwartz 90-kDa Heat Shock Protein Inhibition Abrogates the Topoisomerase I Poison-Induced G2/M Checkpoint in p53-Null Tumor Cells by Depleting Chk1 and Wee1 Mol. Pharmacol., January 1, 2009; 75(1): 124 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kamata, N. Watanabe, Y. Nagaoka, and I. S. Y. Chen Human Immunodeficiency Virus Type 1 Vpr Binds to the N Lobe of the Wee1 Kinase Domain and Enhances Kinase Activity for Cdc2 J. Virol., June 15, 2008; 82(12): 5672 - 5682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1 J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Kim, E. J. Song, K.-J. Lee, and J. E. Ferrell Jr. Multisite M-Phase Phosphorylation of Xenopus Wee1A Mol. Cell. Biol., December 1, 2005; 25(23): 10580 - 10590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Stanford and J. V. Ruderman Changes in Regulatory Phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during Normal Cell Cycle Progression and Checkpoint Arrests Mol. Biol. Cell, December 1, 2005; 16(12): 5749 - 5760. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Katayama, N. Fujita, and T. Tsuruo Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M Transition Mol. Cell. Biol., July 1, 2005; 25(13): 5725 - 5737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Benzinger, N. Muster, H. B. Koch, J. R. Yates III, and H. Hermeking Targeted Proteomic Analysis of 14-3-3{varsigma}, a p53 Effector Commonly Silenced in Cancer Mol. Cell. Proteomics, June 1, 2005; 4(6): 785 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuan, M. Kamata, Y.-M. Xie, and I. S. Y. Chen Increased Levels of Wee-1 Kinase in G2 Are Necessary for Vpr- and Gamma Irradiation-Induced G2 Arrest J. Virol., August 1, 2004; 78(15): 8183 - 8190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. M. Meek, W. S. Lane, and H. Piwnica-Worms Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins J. Biol. Chem., July 30, 2004; 279(31): 32046 - 32054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uchida, A. Kuma, M. Ohtsubo, M. Shimura, M. Hirata, H. Nakagama, T. Matsunaga, Y. Ishizaka, and K. Yamashita Binding of 14-3-3{beta} but not 14-3-3{sigma} controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B J. Cell Sci., June 15, 2004; 117(14): 3011 - 3020. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Kellogg Wee1-dependent mechanisms required for coordination of cell growth and cell division J. Cell Sci., December 15, 2003; 116(24): 4883 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Chen, C. E. Ryan, and H. Piwnica-Worms Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding Mol. Cell. Biol., November 1, 2003; 23(21): 7488 - 7497. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuo, S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda, and H. Okamura Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo Science, October 10, 2003; 302(5643): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Okubo, J. M. Lehman, and T. D. Friedrich Negative Regulation of Mitotic Promoting Factor by the Checkpoint Kinase Chk1 in Simian Virus 40 Lytic Infection J. Virol., December 20, 2002; 77(2): 1257 - 1267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |